news SARS-CoV-2 mAb cocktail effective against all known variants of virus 8 March 2021 | By Victoria Rees (Drug Target Review) A monoclonal antibody (mAb) cocktail, that targets sites on the Spike protein other than the E484K residue, can neutralise SARS-CoV-2.
news Pre-clinical study supports remdesivir as COVID-19 treatment 13 July 2020 | By Hannah Balfour (Drug Target Review) Scientists demonstrated that remdesivir can inhibit SARS-CoV-2 replication in human lung cells and improve lung function in mice with COVID-19.
news Experiments with Marburg virus reveal novel antibody protective mechanisms 22 April 2020 | By Hannah Balfour (Drug Target Review) Researchers discovered the monoclonal antibodies of a convalescent Marburg infection patient bound to the glycoprotein and combatted infection in two novel ways.
news EIDD-2801 shows efficacy against COVID-19 in human cells and mice 7 April 2020 | By Hannah Balfour (Drug Target Review) Collaborators have shown that the broad spectrum oral antiviral EIDD-2801 could be a potential prophylactic or therapeutic for COVID-19 and other coronaviruses.